Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The COVID-19 pandemic has been caused by a novel coronavirus, SARS-CoV-2. Viral infections cause the human immune system to respond in two ways: a fast, non-specific response, and a slow response that produces antibodies that will target the infecting virus. Each antibody will recognize a small segment of the virus, called an epitope. If the best segments to target can be identified, it is possible to manufacture antibodies to test for the infection and help the immune system to boost its response when fighting the infection. Identifying these epitopes manually is a labor-intensive process, that is time consuming and expensive. In the current project, we will use machine learning techniques to gather data of known epitopes and predict new epitopes to new infections. We expect this work will revolutionize the discovery of antibodies when fighting new infections in an epidemic or pandemic context.
Eldad Haber
Philipp Witte
Genomica
Geography / Geology / Earth science
Professional, scientific and technical services
University of British Columbia
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.